Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on INT 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108997214A reveals aqueous synthesis for Lenvatinib intermediate. Reduces solvent waste and enhances supply chain reliability for pharmaceutical manufacturing.
Patent CN103415524B details stereoselective reduction for dorzolamide intermediates. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Patent CN104151352B reveals a high-purity Sofosbuvir intermediate method. This report analyzes cost reduction and supply chain advantages for pharmaceutical manufacturing.
Novel patent CN118638011A offers safer chloramphenicol intermediate synthesis. High yield, reduced hazards, reliable supply chain for pharmaceutical manufacturing.
Patent CN114349618B reveals sulfuric acid method improving selectivity. Reduces energy and cost for scalable photoinitiator manufacturing supply chains.
Patent CN110156645B details a streamlined 2-step asymmetric synthesis for florfenicol intermediates, drastically cutting waste and costs while ensuring high optical purity for veterinary pharmaceutical manufacturing supply chains.
Patent CN111606827B reveals a safer DPPA-based route for Edoxaban intermediates, eliminating metal azides and reducing nitrosamine risks for reliable supply chains.
Patent CN1229372C reveals a novel Reformatsky reaction for Gemcitabine intermediates, offering high selectivity and cost reduction in API manufacturing without chromatography.
Patent CN105348172B details a green synthesis route for Apremilast intermediates. This report analyzes cost reduction and supply chain reliability for pharmaceutical manufacturing.
Discover a novel preparation method for rosuvastatin calcium intermediates featuring mild conditions, high yield, and superior stereocontrol for reliable pharmaceutical manufacturing.
Advanced synthesis of Pemetrexed disodium intermediate via amino protection strategy. Reduces impurities, lowers costs, and ensures reliable supply for oncology drug manufacturing.
Patent CN112939925A reveals a mild synthetic route for long-chain alkanoic acid derivatives, offering cost reduction and scalability for API manufacturing.
Patent CN114149375B reveals a novel route for sulfentrazone intermediates offering higher yield and stability. This report analyzes cost reduction in agrochemical manufacturing and supply chain reliability for global buyers.
Patent CN114085219B details asymmetric hydrogenation for high-purity pharmaceutical intermediates. Offers cost reduction and scalable supply chain solutions for global buyers.
Novel patent CN116768811B offers mild conditions and high yield for topramezone intermediates, ensuring cost reduction and supply reliability for agrochemical manufacturers.
Patent CN103387587B details high-yield Entecavir intermediate synthesis. Offers supply chain reliability and cost reduction for pharmaceutical manufacturing partners.
Novel deoxyfluorination process for Azivudine intermediate offering high purity and safety for pharmaceutical supply chains. Enables cost reduction and scalable manufacturing for global buyers.
Patent CN101768141A details a safer solvent-free synthesis route. Achieve high purity and reduced environmental impact for pharmaceutical intermediate supply chains.
Novel patent CN104557793B offers high-yield Carfilzomib intermediate synthesis. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.